Markets will remain closed on 26^th January, 2021 on account of Republic Day.

Indian Pharma Stocks

Mail
Print
FaceBook
Twitter
Linked In
WhatsApp

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Know More: Which way are the markets & the mutual fund industry headed?

» Result Scoreboard | Best Performing Stocks | Refresh

SCRIP	BSE PRICE (Rs)	NSE PRICE (Rs)	MORE INFO
AARTI DRUGS	717.45 4.55%	718.00 4.65%	More Info
AJANTA PHARMA	1,748.05 1.55%	1,758.95 2.20%	More Info
ALEMBIC PHARMA	960.50 2.11%	961.50 2.29%	More Info
BIOCON	382.70 -2.82%	382.70 -2.81%	More Info
CADILA HEALTHCARE	466.85 1.42%	467.40 1.50%	More Info
CIPLA	837.10 3.60%	836.80 3.53%	More Info
DIVIS LABORATORIES	3,570.80 0.74%	3,569.05 0.69%	More Info
DR. REDDYS LAB	5,082.10 0.96%	5,082.40 0.90%	More Info
GLENMARK PHARMA	491.30 -0.81%	491.40 -0.76%	More Info
INDOCO REMEDIES	311.20 -1.89%	311.50 -1.83%	More Info
IPCA LABS	1,980.90 -3.18%	1,981.55 -3.09%	More Info
J.B.CHEMICALS	1,046.45 5.34%	1,050.40 5.76%	More Info
LUPIN	1,081.85 0.21%	1,081.90 0.25%	More Info
NATCO PHARMA	894.05 -1.23%	894.45 -1.18%	More Info
NIFTY 50	Not Listed	14,238.90 -0.93%	More Info
ORCHID PHARMA	288.50 4.99%	18.90 -2.83%	More Info
PANACEA BIOTECH	197.40 -0.30%	197.20 -0.50%	More Info
PIRAMAL ENTERPRISES	1,466.80 -1.36%	1,467.55 -1.34%	More Info
S&P BSE HEALTHCARE	21,532.11 0.93%	Not Listed	More Info
S&P BSE SENSEX	48,347.59 -1.09%	Not Listed	More Info
STRIDES PHARMA SCIENCE	837.60 -1.19%	837.60 -1.14%	More Info
SUN PHARMA	586.55 2.00%	586.40 1.95%	More Info
TORRENT PHARMA	2,635.90 -2.06%	1,300.00 -3.35%	More Info
WOCKHARDT	496.60 -3.28%	496.80 -3.30%	More Info

BSE prices: January 25, 2021 (Close) NSE prices: January 25, 2021 (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 12,759.5 (up 1.7%). The index is up 23.8% over the last 30 days. And over the last 1 year, it has gained 35.8%.

Within the Indian Pharma sector, the top gainers were J.B.CHEMICALS (up 5.3%) and ORCHID PHARMA (up 5.0%). On the other hand, WOCKHARDT (down 3.3%) and IPCA LABS (down 3.2%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 14,238.9 (down 0.9%).

What else is happening in the markets today? Dig in...

Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

J.B.CHEMICALS Share Price Up by 7%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

J.B.CHEMICALS share price is trading up by 7% and its current market price is Rs 1,066. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index are J.B.CHEMICALS (up 7.2%) and AUROBINDO PHARMA (up 8.0%). The top losers are DR. LAL PATHLABS (down 0.2%) and CAPLIN POINT (down 0.3%).

CIPLA Share Price Up by 5%; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

CIPLA share price is trading up by 5% and its current market price is Rs 850. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are CIPLA (up 5.0%) and AUROBINDO PHARMA (up 9.6%). The top losers are NATCO PHARMA (down 0.2%) and PIRAMAL ENTERPRISES (down 0.6%).

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News